Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Innate Pharma S.A. ADR
(NQ:
IPHA
)
2.460
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.460
Bid (Size)
2.400 (1)
Ask (Size)
2.440 (5)
Prev. Close
2.460
Today's Range
2.460 - 2.460
52wk Range
1.810 - 3.570
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients
April 15, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024
April 15, 2024
From
Innate Pharma SA
Via
Business Wire
Performance
YTD
-9.56%
-9.56%
1 Month
+2.50%
+2.50%
3 Month
-4.75%
-4.75%
6 Month
N/A
N/A
1 Year
-14.29%
-14.29%
More News
Read More
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
April 10, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in Upcoming Investor Conference
April 09, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
April 05, 2024
From
Innate Pharma SA
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 01, 2024
Via
Benzinga
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
March 21, 2024
From
Innate Pharma SA
Via
Business Wire
Earnings Scheduled For March 21, 2024
March 21, 2024
Via
Benzinga
Innate Pharma Announces Its Participation to Upcoming Investor Conference
March 19, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
March 14, 2024
From
Innate Pharma SA
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
March 11, 2024
Via
Benzinga
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
March 06, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
March 06, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation to Upcoming Investor Conference
February 21, 2024
From
Innate Pharma SA
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 06, 2024
Via
Benzinga
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
January 12, 2024
From
Innate Pharma S.A.
Via
Business Wire
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
January 04, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
January 04, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
December 19, 2023
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Leadership Change
December 18, 2023
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
December 11, 2023
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023
December 10, 2023
From
Innate Pharma SA
Via
Business Wire
Innate Pharma to Host Virtual KOL Event on Lacutamab
November 27, 2023
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
November 14, 2023
From
Innate Pharma SA
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.